Using Drug Safety to Push Generics
This article was originally published in RPM Report
Executive Summary
The brandname pharmaceutical industry faces a long list of challenges, but two items top the list: concerns about drug safety following the withdrawal of Merck & Co. Inc.'s rofecoxib (Vioxx) and the wave of blockbuster patent expirations coming in the next several years. If Express Scripts Inc. is right, those two challenges can be combined to make life even tougher for Big Pharma.